MLICM
CDAK

Metropolitan Life Insurance Company (MetLife)’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,152
Closed -$84.1K – 2856
2021
Q3 		$84.1K Buy
+5,152
New +$84.1K ﹤0.01% 2623